Praxis Precision Medicines, Inc.

NASDAQ:PRAX

45.54 (USD) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 007.4630.3020.3570.4310.5150.4680.7810.6830000000000000000
Cost of Revenue 0.04600.04700.1070.1120.1110.3210.3120.3070.3010.2920.3050.2730.5630.5060.3190.20600000000
Gross Profit -0.04607.4160.3020.250.3190.4040.1470.4690.376-0.301-0.292-0.305-0.273-0.563-0.506-0.319-0.20600000000
Gross Profit Ratio 000.99410.70.740.7840.3140.6010.5510000000000000000
Reseach & Development Expenses 63.00660.80656.28841.88127.2626.98418.38817.2625.61425.50428.32930.43943.6252.65243.51133.13925.67817.92916.27212.7869.056.8685.6999.3467.2567.256
General & Administrative Expenses 13.06113.92215.13115.25610.58515.3339.9338.72410.12713.2713.12413.85116.77416.19715.14611.63410.8059.499.443.4312.521.6011.7951.3081.5651.565
Selling & Marketing Expenses 00000000000000000000000000
SG&A 13.01513.92215.13115.25610.58515.3339.9338.72410.12713.2713.12413.85116.77416.19715.14611.63410.8059.499.443.4312.521.6011.7951.3081.5651.565
Other Expenses 00000000.884000.280.3450.20.1320.070.0730.0820000.00500000
Operating Expenses 76.02174.72871.41957.13737.84542.31728.32125.98435.74138.77441.45344.2960.39468.84958.65744.77336.48327.41925.71216.21711.578.4697.49410.6548.8218.821
Operating Income -76.067-74.728-63.956-56.835-37.488-41.886-27.806-25.516-34.96-38.091-41.453-44.29-60.394-68.849-58.657-44.773-36.483-27.419-25.712-16.217-11.57-8.469-7.494-10.654-8.821-8.821
Operating Income Ratio 00-8.57-188.195-105.008-97.183-53.992-54.521-44.763-55.770000000000000000
Total Other Income Expenses Net 4.945.4325.2774.9254.8112.3330.9280.8840.6480.6360.280.3450.20.1320.070.0730.0820.0460.0060.0010.0050.1280.0220.0480.0620.062
Income Before Tax -71.127-69.296-58.679-51.91-32.677-39.553-26.878-24.632-34.312-37.455-41.173-43.945-60.194-68.717-58.587-44.7-36.401-27.373-25.706-16.216-11.565-8.341-7.472-10.606-8.759-8.759
Income Before Tax Ratio 00-7.863-171.887-91.532-91.77-52.19-52.632-43.933-54.8390000000000000000
Income Tax Expense 0000-0.107-0.1120-0.109-0.016-0.636-0.28-0.345-0.2-0.132-0.0050.005-0.292-0.1830.00800.003-0.011-0.08401.0921.092
Net Income -71.127-69.296-58.679-51.91-32.677-39.553-26.878-24.632-34.312-36.819-40.893-43.6-59.994-68.585-58.582-44.705-36.401-27.373-25.706-16.216-11.568-8.33-7.388-10.606-9.851-9.851
Net Income Ratio 00-7.863-171.887-91.532-91.77-52.19-52.632-43.933-53.9080000000000000000
EPS -3.312-3.29-2.94-2.75-1.74-2.84-2.97-2.72-7.38-10.4-12.89-14.29-19.76-22.63-19.54-15-13.13-10.67-12.56-146.01-105.64-76.69-68.71-101.99-100.35-100.35
EPS Diluted -3.312-3.29-2.94-2.75-1.74-2.84-2.97-2.72-7.38-10.4-12.89-14.29-19.76-22.63-19.54-15-13.13-10.67-12.56-146.01-105.64-76.69-68.71-101.99-100.35-100.35
EBITDA -71.081-74.681-63.909-56.743-37.381-41.774-27.695-25.407-34.854-37.985-41.348-44.188-60.394-68.756-58.564-44.734-36.456-27.396-25.692-16.207-11.56-8.459-7.297-10.644-8.812-8.812
EBITDA Ratio 00-8.563-187.891-104.709-96.923-53.777-54.288-44.627-55.6150000000000000000